HTL-0039732

N/A

Report date: 2025/03/26 20:01:25
NME

Base Information

Drug NameHTL-0039732
Drug Alias NameHTL0039732
ClassificationSmall molecules
Mechanisms of ActionProstanoid EP4 receptor antagonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsUrinary Bladder NeoplasmsKidney NeoplasmsProstatic Neoplasms, Castration-Resistant +[14
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNxera Pharma UK Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsKidney NeoplasmsProstatic Neoplasms, Castration-Resistant +[13
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A